Healthcare, Pharma & Life Sciences

Boston – – October 08, 2026 -- Araceli Biosciences and Ginkgo Bioworks (NYSE: DNA) have integrated Araceli's Endeavor high-content imaging instrument into Nebula, Ginkgo's autonomous laboratory in Boston, adding what the companies describe as the world's fastest high-content imaging system to a facility already running more than 100 automated carts around the clock.

Endeavor images a 1536-well plate in under four minutes

The Endeavor instrument captures and analyzes cellular data from a full 1536-well plate in less than four minutes, running continuously alongside Nebula's other always-on experiments. The system is built on Ginkgo's Reconfigurable Automation Carts (RACs), modular units combining robotic arms, automated sample transport and unified control software that let instruments be added or rearranged as research workflows shift.

Hong Kong – October 08, 2026 -- Sisram Medical Ltd (1696.HK) has announced a share repurchase plan to buy back up to 1% of its total issued shares on the open market, citing confidence in its long-term growth trajectory.

Buyback plan allows cancellation or treasury retention of shares

Under the existing share repurchase mandate, repurchased shares may either be cancelled or held as treasury shares depending on future capital management needs. The plan will be executed subject to market conditions, with the Board stating it will balance business development priorities, strategic investment needs and financial flexibility.

First-half 2026 revenue climbs 3.6% to US$171.4 million

Sisram reported H1 2026 revenue of US$171.4 million, up 3.6% year-on-year. International markets excluding North America drove growth, rising 16.7% YoY to US$127.0 million, with APAC generating US$78.4 million, a 19.1% YoY increase.

Sitges – October 08, 2026 -- MGI Tech Co., Ltd. unveiled its Stereo-seq OMNI Large Chip Design for formalin-fixed, paraffin-embedded (FFPE) tissue samples at the third Conference of the European Society for Spatial Biology (ESSB), held September 28 to October 1 at Hotel Meliá Sitges near Barcelona.

New chip format expands capture area to 2 cm by 3 cm for FFPE research

The design builds on MGI's existing Stereo-seq OMNI V1.1 platform and is built for chip formats up to 2 cm by 3 cm, enabling researchers to profile larger tissues, multiple sections, or tissue microarray layouts within a single spatial experiment. Standard capture areas have limited researchers' ability to view larger or structurally diverse FFPE sections, a constraint the new format is engineered to address.

Gwacheon, South Korea – – October 08, 2026 -- Park Systems Corp. captured 23.8% of global atomic force microscopy (AFM) revenue in 2025, retaining the top industry ranking for a fourth consecutive year from 2022 through 2025, according to QY Research's Global Atomic Force Microscopy Market Report.

Park Systems leads both revenue and unit shipments in 2025

The South Korea-based company sold 340 AFM systems during the year, the highest unit volume among manufacturers tracked in the study, while also topping the market on revenue share.

New Haven, Conn. – October 08, 2026 -- Biohaven Ltd. (NYSE: BHVN) has signed a licensing and collaboration agreement with Ono Pharmaceutical Co., Ltd. (TYO: 4528), granting Ono exclusive rights to develop and commercialize Biohaven's MoDE pan IgG degrader portfolio across Japan, South Korea, Taiwan, and ASEAN member states.

Biohaven secures up to $100 million in near-term payments from Ono

The deal includes $80 million paid at execution and a further $20 million tied to a milestone expected within a year. Biohaven will also receive royalties of approximately 20 percent on net sales generated by Ono within the licensed territory. Biohaven retains all rights to the portfolio outside this region, including the United States, Europe, and China.

Allentown, Pa. – – October 08, 2026 -- AblePay Health has closed a $20 million Series A financing round led by F-Prime, with participation from A1 Health Ventures and .406 Ventures, to expand its healthcare payment platform for patients and providers.

Out-of-pocket medical costs hit $591 billion in 2025, up 6% year-over-year

According to the Centers for Medicare & Medicaid Services, Americans paid $591 billion out of pocket for healthcare in 2025, a 6% increase from the prior year. The rising burden leaves providers more exposed to patient payment risk, tying revenue cycle performance directly to patients' ability and willingness to pay.

Suzhou – October 08, 2026 -- Suzhou Ribo Life Science (06938.HK) and its Swedish subsidiary Ribocure Pharmaceuticals AB have submitted a Phase I Clinical Trial Application in the European Union for RBD3133, a small interfering RNA (siRNA) therapeutic targeting the INHBE gene for overweight and obesity.

RBD3133 silences a gene linked to healthier fat distribution in human genetic studies

RBD3133 is designed to selectively suppress INHBE, which encodes the protein activin E. Human genetic data show that individuals with naturally occurring loss-of-function variants in INHBE exhibit healthier fat distribution, improved metabolic profiles, and a lower estimated risk of coronary heart disease and type 2 diabetes.

Shanghai – October 08, 2026 -- WuXi AppTec has secured its third consecutive Gold medal from EcoVadis, placing the pharmaceutical CRDMO among the top 5% of companies worldwide for sustainability performance.

EcoVadis scores companies across 21 criteria covering four pillars

The rating agency evaluates global supply-chain participants on Environment, Labor & Human Rights, Ethics, and Sustainable Procurement, with Gold medals reserved for the highest percentile tier. WuXi AppTec's repeat award signals sustained compliance across its value chain rather than a one-time achievement.

Torrington, Conn. – October 08, 2026 -- Therap Services hosted a virtual event, "Program Integrity for States and Providers: How to Identify and Avoid Fraud, Waste, and Abuse," drawing more than 1,000 registrants including state directors, agency administrators and CEOs across the IDD, HCBS and LTSS sectors.

Virtual Event Draws Over 1,000 Registrants Amid Rising Medicaid Scrutiny

The session addressed evolving Medicaid compliance requirements and strategies to identify and avoid fraud, waste, and abuse (FWA). Presenters covered the changing Medicaid and HCBS regulatory landscape, state enforcement trends, the 2027 Medicaid Employment Mandate, and provider enrollment moratoriums.

Milford, Mass. – October 08, 2026 -- Highbar Physical Therapy opened its 57th outpatient clinic in Milford, Massachusetts, expanding a network that began as a single Pawtucket, R.I. practice in 1999.

Clinician-led chain traces roots to 1999 Rhode Island clinic

Highbar started as Performance Physical Therapy in Pawtucket before adopting the Highbar name in 2023. The organization now operates 57 locations across Rhode Island and Massachusetts under four brands: Highbar Physical Therapy, Joint Ventures Physical Therapy, Peak Physical Therapy, and Physical Therapy U.

CEO frames Milford launch as continuation of uniform clinical standard

"Milford is our 57th location, and the standard is the same in every clinic," said Michelle Collie, PT, DPT, MS, CEO of Highbar Physical Therapy. Brian Simons, PT, DPT, NCS, Clinic Director at the new Milford site, said the goal is "expert, individualized care close to home."